Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

562 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Image-Guided Magnetic Thermoseed Navigation and Tumor Ablation Using a Magnetic Resonance Imaging System.
Baker RR, Payne C, Yu Y, Mohseni M, Connell JJ, Lin F, Harrison IF, Southern P, Rudrapatna US, Stuckey DJ, Kalber TL, Siow B, Thorne L, Punwani S, Jones DK, Emberton M, Pankhurst QA, Lythgoe MF. Baker RR, et al. Among authors: emberton m. Adv Sci (Weinh). 2022 Apr;9(12):e2105333. doi: 10.1002/advs.202105333. Epub 2022 Feb 2. Adv Sci (Weinh). 2022. PMID: 35106965 Free PMC article.
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting.
Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin PJ, Kirkham A, Padhani AR, Persad R, Puech P, Punwani S, Sohaib AS, Tombal B, Villers A, van der Meulen J, Emberton M. Dickinson L, et al. Among authors: emberton m. Eur Urol. 2011 Apr;59(4):477-94. doi: 10.1016/j.eururo.2010.12.009. Epub 2010 Dec 21. Eur Urol. 2011. PMID: 21195536
Scoring systems used for the interpretation and reporting of multiparametric MRI for prostate cancer detection, localization, and characterization: could standardization lead to improved utilization of imaging within the diagnostic pathway?
Dickinson L, Ahmed HU, Allen C, Barentsz JO, Carey B, Futterer JJ, Heijmink SW, Hoskin P, Kirkham AP, Padhani AR, Persad R, Puech P, Punwani S, Sohaib A, Tombal B, Villers A, Emberton M. Dickinson L, et al. Among authors: emberton m. J Magn Reson Imaging. 2013 Jan;37(1):48-58. doi: 10.1002/jmri.23689. Epub 2012 May 7. J Magn Reson Imaging. 2013. PMID: 22566285 Review.
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group.
Moore CM, Kasivisvanathan V, Eggener S, Emberton M, Fütterer JJ, Gill IS, Grubb Iii RL, Hadaschik B, Klotz L, Margolis DJ, Marks LS, Melamed J, Oto A, Palmer SL, Pinto P, Puech P, Punwani S, Rosenkrantz AB, Schoots IG, Simon R, Taneja SS, Turkbey B, Ukimura O, van der Meulen J, Villers A, Watanabe Y; START Consortium. Moore CM, et al. Among authors: emberton m. Eur Urol. 2013 Oct;64(4):544-52. doi: 10.1016/j.eururo.2013.03.030. Epub 2013 Mar 20. Eur Urol. 2013. PMID: 23537686
The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation.
Simmons LA, Ahmed HU, Moore CM, Punwani S, Freeman A, Hu Y, Barratt D, Charman SC, Van der Meulen J, Emberton M. Simmons LA, et al. Among authors: emberton m. Contemp Clin Trials. 2014 Jan;37(1):69-83. doi: 10.1016/j.cct.2013.11.009. Epub 2013 Nov 28. Contemp Clin Trials. 2014. PMID: 24291455
Re: Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study: J. E. Thompson, D. Moses, R. Shnier, P. Brenner, W. Delprado, L. Ponsky, M. Pulbrook, M. Böhm, A.-M. Haynes, A. Hayen and P. D. Stricker J Urol 2014;192:67-74.
El-Shater Bosaily A, Arya M, Punwani S, Emberton M, Kirkham A, Freeman A, Ahmed HU. El-Shater Bosaily A, et al. Among authors: emberton m. J Urol. 2015 Feb;193(2):735-6; discussion 736. doi: 10.1016/j.juro.2014.08.118. Epub 2014 Nov 12. J Urol. 2015. PMID: 25445580 No abstract available.
Multiparametric MRI for detection of radiorecurrent prostate cancer: added value of apparent diffusion coefficient maps and dynamic contrast-enhanced images.
Abd-Alazeez M, Ramachandran N, Dikaios N, Ahmed HU, Emberton M, Kirkham A, Arya M, Taylor S, Halligan S, Punwani S. Abd-Alazeez M, et al. Among authors: emberton m. Prostate Cancer Prostatic Dis. 2015 Jun;18(2):128-36. doi: 10.1038/pcan.2014.55. Epub 2015 Feb 3. Prostate Cancer Prostatic Dis. 2015. PMID: 25644248
562 results